M. Nagatake

In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.

R. Ueda, H. Osada, T. Koshikawa, 1995, Cancer research.

Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.

Y. Yatabe, T. Mitsudomi, T. Koshikawa, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.

H. Osada, K. Shimokata, T. Takahashi, 1996, Cancer research.

Advances in Brief In Vivo Occurrence of pl 6 ( MTS 1 ) and pl 5 ( MTS 2 ) Alterations Preferentially in Non-Small Cell Lung Cancers 1

R. Ueda, H. Osada, Takashi Takahashi, 2006 .

Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.

T. Mitsudomi, H. Osada, K. Shimokata, 1996, Cancer research.

Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.

Y. Yatabe, T. Mitsudomi, H. Osada, 1996, Cancer research.

Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.

S. Elledge, J. Harper, H. Osada, 1996, Oncogene.

Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers

K. Yanagisawa, H. Osada, Takashi Takahashi, 2000, Oncogene.

E-mail alerts Sign up to receive free email-alerts related to this article or journal. Reprints and Subscriptions Permissions

T. Mitsudomi, H. Osada, K. Shimokata, 1947 .

Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.

Hiromu Suzuki, R. Ueda, H. Osada, 1996, Oncogene.